ASHLEY MARTIN: Open Payments
NPI 1679948442 · GOLDEN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 88 payments from 18 companies in 2025. Trend: 2023 $1,487 · 2024 $1,612 · 2025 $1,628
Food & beverage: $1,467Education: $161
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 23 | $202 |
| Organon LLC | 10 | $176 |
| Regeneron Healthcare Solutions, Inc. | 5 | $174 |
| GENZYME CORPORATION | 6 | $170 |
| Arcutis Biotherapeutics, Inc. | 11 | $154 |
| Novartis Pharmaceuticals Corporation | 6 | $149 |
| PFIZER INC. | 5 | $92 |
| Janssen Biotech, Inc. | 2 | $91 |
| LEO Pharma Inc. | 3 | $76 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $61 |
Products named: DUPIXENT, NEMLUVIO, Zoryve, CIBINQO, TREMFYA, VTAMA, Cabtreo, Rhapsido.
Industry payments across CO — which companies pay providers there.
